Ethical issues in assisted reproduction

Pandey, Shilpi; Hamilton, Mark

doi:10.1016/j.ogrm.2012.12.005

Cited by 2 publications

(4 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Medical responsibility is a vague notion in the context of CBRS . From a moral perspective, physicians are bound by their duty to care for their patients regardless of treatment geography .…”

Section: Resultsmentioning

confidence: 99%

“…Whittaker reported networks of facilitators and foreign investment capitalizing on economical and legal disparities . CBRS may produce social discrimination where only wealthy couples are able to access foreign high‐tech technology and its medical benefits . It creates a two‐tier system in the provider country where wealthy international patients are privileged over the local populace .…”

Section: Resultsmentioning

confidence: 99%

“…Policy issues are the most common reasons used empirically and theoretically to explain CBRS (10,11,23,30,32,34,36,37,39,40,43,(45)(46)(47)(48)(49)(50)(51)(52). Along with surrogacy and gamete donation, sex selection, PGD and PGS are the most banned and heavily restricted reproductive technologies (32).…”

Section: Motivationsmentioning

confidence: 99%

“…Practicality difficulties in accessing local reprogenetic services represent an important incentive for people or samples to cross-borders (10,32,55). The absence of PGD services or tests for specific diseases, the scarcity of resources or the presence of prohibitive waiting lists may be involved in characterizing limited accessibility (41,50). PGD necessitates a high-level of expertise (10,32) and equipment that are not available in all regions (10,32,41,51,52,56).…”

Section: Motivationsmentioning

confidence: 99%

See 3 more Smart Citations

Cross‐border reprogenetic services

et al. 2014

View full text Add to dashboard Cite

The purpose of this review is to synthesize the current knowledge on the international movement of patients and biopsied embryo cells for pre-implantation genetic diagnosis and its different applications. Thus far, few attempts have been made to identify the specific nature of this phenomenon called 'cross-border reprogenetic services'. There is scattered evidence, both empirical and speculative, suggesting that these services raise major issues in terms of service provision, risks for patients and the children-to-come, the legal liabilities of physicians, as well as social justice. To compile this evidence, this review uses the narrative overview protocol combined with thematic analysis. Five major themes have emerged from the literature at the conjunction of cross-border treatments and reprogenetics: 'scope', 'scale', 'motivations', 'concerns', and 'governance'. Similar themes have already been observed in the case of other medical tourism activities, but this review highlights their singularity with reprogenetic services. It emphasizes the diagnostic and autologous feature of reprogenetics, the constant risk of misdiagnosis, the restriction on certain tests for medically controversial conditions, and the uncertain accessibility of genetic counseling in cross-border settings.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%